Rhythm Pharmaceuticals
Rhythm Pharmaceuticals - Rhythm is developing peptide therapeutics for the treatment of rare genetic deficiencies that result in life-threatening metabolic disorders..
Launch date
Employees
Market cap
AUD4.7b
Enterprise valuation
AUD4.4b (Public information from Sep 2024)
Share price
$54.55 RYTM
Boston Massachusetts (HQ)
Authorizing premium user...